传染病。埃博拉疫苗：太少且太晚。 - Suppr

Suppr

超能文献

Infectious disease. Ebola vaccine: little and late.

作者信息

Cohen Jon

出版信息

Science. 2014 Sep 19;345(6203):1441-2. doi: 10.1126/science.345.6203.1441.

DOI:10.1126/science.345.6203.1441

PMID:25237082

Abstract

摘要

相似文献

Infectious disease. Ebola vaccine: little and late.

Science. 2014 Sep 19;345(6203):1441-2. doi: 10.1126/science.345.6203.1441.

Ebola treatments caught in limbo.

Nature. 2014 Jul 31;511(7511):520. doi: 10.1038/511520a.

US plans to deploy 3000 army personnel to tackle Ebola in west Africa.

BMJ. 2014 Sep 18;348:g5727. doi: 10.1136/bmj.g5727.

Ebola's perfect storm.

Science. 2014 Sep 12;345(6202):1221. doi: 10.1126/science.1260695.

Clinical trials of Ebola vaccine must continue despite fall in number of cases.

BMJ. 2015 Feb 17;350:h944. doi: 10.1136/bmj.h944.

Addressing fear, fighting complacency.

Clin Pharmacol Ther. 2015 Oct;98(4):359-61. doi: 10.1002/cpt.162. Epub 2015 Aug 29.

Using the Ebola outbreak as an opportunity to educate on vaccine utility.

J Bioeth Inq. 2014 Dec;11(4):415-6. doi: 10.1007/s11673-014-9590-8. Epub 2014 Nov 25.

The evolution of Ebola virus disease outbreaks.

Folia Med Cracov. 2014;54(3):27-32.

A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.

Clin Trials. 2016 Feb;13(1):101-4. doi: 10.1177/1740774515619860. Epub 2016 Jan 14.

Ebola R&D woes spur action.

Nature. 2015 May 28;521(7553):405-6. doi: 10.1038/521405a.

引用本文的文献

The Coming of Age of Nucleic Acid Vaccines during COVID-19.

ArXiv. 2023 Jan 24:arXiv:2210.07247v2.

Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks.

PLoS Negl Trop Dis. 2018 Apr 5;12(4):e0006275. doi: 10.1371/journal.pntd.0006275. eCollection 2018 Apr.

Vaccine development for emerging virulent infectious diseases.

Vaccine. 2017 Oct 4;35(41):5437-5443. doi: 10.1016/j.vaccine.2017.02.015. Epub 2017 Feb 16.

A web-based resource for designing therapeutics against Ebola Virus.

Sci Rep. 2016 Apr 26;6:24782. doi: 10.1038/srep24782.

Convalescent plasma: new evidence for an old therapeutic tool?

Blood Transfus. 2016 Mar;14(2):152-7. doi: 10.2450/2015.0131-15. Epub 2015 Nov 6.

Modeling the transmission dynamics of Ebola virus disease in Liberia.

Sci Rep. 2015 Sep 8;5:13857. doi: 10.1038/srep13857.

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs.

Emerg Microbes Infect. 2014 Dec;3(12):e84. doi: 10.1038/emi.2014.88. Epub 2014 Dec 17.

A vaccine against Ebola: Problems and opportunities.

Hum Vaccin Immunother. 2015;11(5):1258-60. doi: 10.1080/21645515.2015.1021528.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Infectious disease. Ebola vaccine: little and late.

Science. 2014 Sep 19;345(6203):1441-2. doi: 10.1126/science.345.6203.1441.

Ebola treatments caught in limbo.

Nature. 2014 Jul 31;511(7511):520. doi: 10.1038/511520a.

US plans to deploy 3000 army personnel to tackle Ebola in west Africa.

BMJ. 2014 Sep 18;348:g5727. doi: 10.1136/bmj.g5727.

Ebola's perfect storm.

Science. 2014 Sep 12;345(6202):1221. doi: 10.1126/science.1260695.

Clinical trials of Ebola vaccine must continue despite fall in number of cases.

BMJ. 2015 Feb 17;350:h944. doi: 10.1136/bmj.h944.

Addressing fear, fighting complacency.

Clin Pharmacol Ther. 2015 Oct;98(4):359-61. doi: 10.1002/cpt.162. Epub 2015 Aug 29.

Using the Ebola outbreak as an opportunity to educate on vaccine utility.

J Bioeth Inq. 2014 Dec;11(4):415-6. doi: 10.1007/s11673-014-9590-8. Epub 2014 Nov 25.

The evolution of Ebola virus disease outbreaks.

Folia Med Cracov. 2014;54(3):27-32.

A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.

Clin Trials. 2016 Feb;13(1):101-4. doi: 10.1177/1740774515619860. Epub 2016 Jan 14.

Ebola R&D woes spur action.

Nature. 2015 May 28;521(7553):405-6. doi: 10.1038/521405a.

引用本文的文献

The Coming of Age of Nucleic Acid Vaccines during COVID-19.

ArXiv. 2023 Jan 24:arXiv:2210.07247v2.

Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks.

PLoS Negl Trop Dis. 2018 Apr 5;12(4):e0006275. doi: 10.1371/journal.pntd.0006275. eCollection 2018 Apr.

Vaccine development for emerging virulent infectious diseases.

Vaccine. 2017 Oct 4;35(41):5437-5443. doi: 10.1016/j.vaccine.2017.02.015. Epub 2017 Feb 16.

A web-based resource for designing therapeutics against Ebola Virus.

Sci Rep. 2016 Apr 26;6:24782. doi: 10.1038/srep24782.

Convalescent plasma: new evidence for an old therapeutic tool?

Blood Transfus. 2016 Mar;14(2):152-7. doi: 10.2450/2015.0131-15. Epub 2015 Nov 6.

Modeling the transmission dynamics of Ebola virus disease in Liberia.

Sci Rep. 2015 Sep 8;5:13857. doi: 10.1038/srep13857.

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs.

Emerg Microbes Infect. 2014 Dec;3(12):e84. doi: 10.1038/emi.2014.88. Epub 2014 Dec 17.

A vaccine against Ebola: Problems and opportunities.

Hum Vaccin Immunother. 2015;11(5):1258-60. doi: 10.1080/21645515.2015.1021528.